Logo image of BRKR

BRUKER CORP (BRKR) Stock Overview

USA - NASDAQ:BRKR - US1167941087 - Common Stock

38.72 USD
+0.08 (+0.21%)
Last: 10/28/2025, 8:00:01 PM
38.72 USD
0 (0%)
Pre-Market: 10/29/2025, 6:05:00 AM

BRKR Key Statistics, Chart & Performance

Key Statistics
Market Cap5.87B
Revenue(TTM)3.44B
Net Income(TTM)79.60M
Shares151.72M
Float103.16M
52 Week High64.64
52 Week Low28.53
Yearly Dividend0.2
Dividend Yield0.5%
EPS(TTM)2.15
PE18.01
Fwd PE16.65
Earnings (Next)11-03 2025-11-03/bmo
IPO2000-08-04
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


BRKR short term performance overview.The bars show the price performance of BRKR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

BRKR long term performance overview.The bars show the price performance of BRKR in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of BRKR is 38.72 USD. In the past month the price increased by 19.18%. In the past year, price decreased by -34.69%.

BRUKER CORP / BRKR Daily stock chart

BRKR Latest News, Press Relases and Analysis

BRKR Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 24.89 210.57B
DHR DANAHER CORP 28.13 155.31B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 143.51 46.81B
A AGILENT TECHNOLOGIES INC 26.76 41.35B
IQV IQVIA HOLDINGS INC 18.76 37.08B
MTD METTLER-TOLEDO INTERNATIONAL 34.34 28.93B
WAT WATERS CORP 28.29 20.59B
WST WEST PHARMACEUTICAL SERVICES 40.1 20.39B
MEDP MEDPACE HOLDINGS INC 40.6 16.31B
TEM TEMPUS AI INC N/A 15.04B
ILMN ILLUMINA INC 23.51 15.03B
ICLR ICON PLC 13.47 13.82B

About BRKR

Company Profile

BRKR logo image Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Company Info

BRUKER CORP

40 Manning Rd

Billerica MASSACHUSETTS 01821 US

CEO: Frank H. Laukien

Employees: 11396

BRKR Company Website

BRKR Investor Relations

Phone: 19786633660

BRUKER CORP / BRKR FAQ

Can you describe the business of BRUKER CORP?

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.


What is the stock price of BRUKER CORP today?

The current stock price of BRKR is 38.72 USD. The price increased by 0.21% in the last trading session.


What is the dividend status of BRUKER CORP?

BRUKER CORP (BRKR) has a dividend yield of 0.5%. The yearly dividend amount is currently 0.2.


How is the ChartMill rating for BRUKER CORP?

BRKR has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the PE ratio for BRKR stock?

The PE ratio for BRUKER CORP (BRKR) is 18.01. This is based on the reported non-GAAP earnings per share of 2.15 and the current share price of 38.72 USD.


Should I buy BRKR stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BRKR.


What is the outstanding short interest for BRUKER CORP?

The outstanding short interest for BRUKER CORP (BRKR) is 12.94% of its float.


BRKR Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to BRKR. When comparing the yearly performance of all stocks, BRKR is a bad performer in the overall market: 87.75% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BRKR Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to BRKR. BRKR has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BRKR Financial Highlights

Over the last trailing twelve months BRKR reported a non-GAAP Earnings per Share(EPS) of 2.15. The EPS decreased by -16.99% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.31%
ROA 1.26%
ROE 4.41%
Debt/Equity 1.32
Chartmill High Growth Momentum
EPS Q2Q%-38.46%
Sales Q2Q%-0.41%
EPS 1Y (TTM)-16.99%
Revenue 1Y (TTM)10.36%

BRKR Forecast & Estimates

21 analysts have analysed BRKR and the average price target is 45.76 USD. This implies a price increase of 18.18% is expected in the next year compared to the current price of 38.72.

For the next year, analysts expect an EPS growth of -17.04% and a revenue growth 2.63% for BRKR


Analysts
Analysts76.19
Price Target45.76 (18.18%)
EPS Next Y-17.04%
Revenue Next Year2.63%

BRKR Ownership

Ownership
Inst Owners84.43%
Ins Owners26.98%
Short Float %12.94%
Short Ratio3.41